McKnight's Long-Term Care News

Oral liquid of spironolactone available

CMP Pharma announced its CaroSpir is the first FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone. CaroSpir oral suspension, in a banana flavor, allows adult ...
Pharmabiz

Scienture and BlinkRx collaborate to expand patient access to Arbli, an oral suspension formulation of losartan potassium

Scienture and BlinkRx collaborate to expand patient access to Arbli, an oral suspension formulation of losartan potassium: Commack, New York Friday, December 12, 2025, 14:00 Hrs [ ...
Nasdaq

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan ...

TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- – SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced ...

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

U.S. Losartan market totals $245M annually with 71M prescriptions COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC.

Why Is Scienture Stock Gaining Today?

Scienture stock is climbing after the company partnered with BlinkRx to expand national access to its new FDA-approved liquid losartan therapy, Arbli.
clinicaladvisor.com

RAISING A LOW POTASSIUM

Optimal treatment for hypokalemia depends on the severity of the potassium deficit and the underlying etiology. In general, when a patient has mild-to-moderate hypokalemia (serum potassium between 3.0 ...